NSR AAV-MD

N/A

Report date: 2023/10/26 16:47:30

Base Information

Drug NameNSR AAV-MD

Drug Alias NameAAV-MD

ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector

Mechanisms of ActionGene transference

TargetsUpdating

Therapy Area/IndicationsMacular Degeneration

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesNightstarx Ltd

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesBiogen Inc

Active IndicationsN/A

Inactive IndicationsMacular Degeneration

ATC CodeN/A